Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Juan M Ponce-Guarneros"'
Autor:
Fabiola Gonzalez-Ponce, Jorge I Gamez-Nava, Emilio E Perez-Guerrero, Ana M Saldaña-Cruz, Maria L Vazquez-Villegas, Juan M Ponce-Guarneros, Miguel Huerta, Xochitl Trujillo, Betsabe Contreras-Haro, Alberto D Rocha-Muñoz, Maria O Carrillo-Escalante, Esther N Sanchez-Rodriguez, Eli E Gomez-Ramirez, Cesar A Nava-Valdivia, Ernesto G Cardona-Muñoz, Laura Gonzalez-Lopez, Research Group for the Assessment of Prognosis Biomarkers in Autoimmune Disorders
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0255854 (2021)
BackgroundChemerin has a potential role in perpetuating inflammation in autoimmune diseases. Nevertheless, to date, there is no conclusive information on whether high chemerin levels increase the severity of rheumatoid arthritis (RA). Therefore, this
Externí odkaz:
https://doaj.org/article/20f724e9c1af410cbf6a1606d7a3dde3
Autor:
Juan A. Peraza-Zaldivar MD, Juan M. Ponce-Guarneros PhD, Ernesto G. Cardona-Muñoz PhD, Yussef Esparza-Guerrero PhD, Ana M. Saldaña-Cruz PhD, Sergio A. González-Vazquez MD, Laura Gonzalez-Lopez PhD, Jorge I. Gamez-Nava PhD, Norma A. Rodriguez-Jimenez PhD
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics, Vol 28 (2023)
Introduction Metabolic syndrome (MS) is associated with abnormalities in atrial mechanics, atrial remodeling, and an increased risk of heart rhythm disorders. One of the most commonly used approaches to the prevention of cardiac remodeling in arteria
Externí odkaz:
https://doaj.org/article/908ee5b363a94439ae34ec00a1110635
Autor:
Eli E. Gomez-Ramirez, Melissa Ramirez-Villafaña, Jorge I. Gamez-Nava, Fidencio Cons-Molina, Norma A. Rodriguez Jimenez, Ana M. Saldaña-Cruz, Ernesto G. Cardona-Muñoz, Sylvia E. Totsuka-Sutto, Juan M. Ponce-Guarneros, Xochitl Trujillo, Miguel Huerta, Alfonso J. Cruz-Jentoft, Laura Gonzalez-Lopez
Publikováno v:
Healthcare, Vol 10, Iss 10, p 2004 (2022)
Background: Muscle wasting, also known as myopenia, is frequent in rheumatoid arthritis (RA). To date, it is still unknown if the failure of pharmacologic therapies increases the risk of myopenia in RA. Objective: To identify if treatment failure wit
Externí odkaz:
https://doaj.org/article/9065f187a52d46af85d00073d9333586
Autor:
Nicte S, Fajardo-Robledo, Heriberto, Jacobo-Cuevas, Edsaul E, Perez-Guerrero, Esther G, Corona-Sanchez, A Miriam, Saldaña-Cruz, Elba M, Romero-Tejeda, N Alejandra, Rodriguez-Jimenez, Sylvia E, Totsuka-Sutto, Rocio I, Lopez-Roa, Juan M, Ponce-Guarneros, M Fabiola, Alcaraz-Lopez, Sergio, Cerpa-Cruz, J Francisco, Muñoz-Valle, E German, Cardona-Muñoz, Laura, Gonzalez-Lopez, Jorge I, Gamez-Nava, Jorge Ivan, Gamez-Nava
Publikováno v:
Scientific Reports
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
There is a significant rate of therapeutic failure in rheumatoid arthritis (RA) patients treated with leflunomide (LEF). This study investigates the utility values of teriflunomide levels (A77 1726) in identifying RA patients who remained with modera
Autor:
Nicte S. Fajardo-Robledo, Heriberto Jacobo-Cuevas, Edsaul E. Perez-Guerrero, Esther G. Corona-Sanchez, A. Miriam Saldaña-Cruz, Elba M. Romero-Tejeda, N. Alejandra Rodriguez-Jimenez, Sylvia E. Totsuka-Sutto, Rocio I. Lopez-Roa, Juan M. Ponce-Guarneros, M. Fabiola Alcaraz-Lopez, Sergio Cerpa-Cruz, J. Francisco Muñoz-Valle, E. German Cardona-Muñoz, Laura Gonzalez-Lopez, Jorge I. Gamez-Nava, Research Group for Factors Related to Therapeutic Outcomes in Autoimmune Diseases
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract There is a significant rate of therapeutic failure in rheumatoid arthritis (RA) patients treated with leflunomide (LEF). This study investigates the utility values of teriflunomide levels (A77 1726) in identifying RA patients who remained wi
Externí odkaz:
https://doaj.org/article/4456a41bc2d24fa7bb0335a00d34a342
Autor:
Maria Luisa Vazquez-Villegas, Jorge I. Gamez-Nava, A. Miriam Saldaña-Cruz, Alfredo Celis, Esther N. Sanchez-Rodriguez, Edsaul Emilio Perez-Guerrero, Melissa Ramirez-Villafaña, Cesar Arturo Nava-Valdivia, Betsabe Contreras-Haro, Jose C. Vasquez-Jimenez, Juan M. Ponce-Guarneros, Ana K. Barocio-Ramirez, Sergio Cerpa-Cruz, Miriam F. Alcaraz-Lopez, Laura Gonzalez-Lopez
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Adipokines, especially chemerin, can interact with cytokines and other molecules in inflammation. To date, there is insufficient information regarding a possible correlation between functional disability and chemerin and other pro-inflammato
Externí odkaz:
https://doaj.org/article/063671eb263042d2ba62f1392ed3d4a2